Hwail Pharmaceutical Co.,Ltd. 061250.KQ Stock
1571 KRW
{{ price }}
-1.566416%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
100.85B KRW
LOW - HIGH [24H]
1563
-
1595 KRW
VOLUME [24H]
52.22K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
Hwail Pharmaceutical Co.,Ltd. Price Chart
Hwail Pharmaceutical Co.,Ltd. 061250.KQ Financial and Trading Overview
| Hwail Pharmaceutical Co.,Ltd. stock price | 1571 KRW |
| Previous Close | 2065 KRW |
| Open | 2060 KRW |
| Bid | 2075 KRW x 0 |
| Ask | 2085 KRW x 0 |
| Day's Range | 2060 - 2100 KRW |
| 52 Week Range | 1840 - 3270 KRW |
| Volume | 233.25K KRW |
| Avg. Volume | 854.51K KRW |
| Market Cap | 28.26B KRW |
| Beta (5Y Monthly) | -0.139301 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
061250.KQ Valuation Measures
| Enterprise Value | 96.49B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.26199716 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.894 |
| Enterprise Value/EBITDA | 18.557 |
Trading Information
Hwail Pharmaceutical Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | -0.139301 |
| 52-Week Change | -28.17% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3270 KRW |
| 52 Week Low | 1840 KRW |
| 50-Day Moving Average | 2159.7 KRW |
| 200-Day Moving Average | 2297.58 KRW |
061250.KQ Share Statistics
| Avg. Volume (3 month) | 854.51K KRW |
| Avg. Daily Volume (10-Days) | 646.05K KRW |
| Shares Outstanding | 13.52M |
| Float | 24.15M |
| Short Ratio | N/A |
| % Held by Insiders | 44.64% |
| % Held by Institutions | 1.30% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 3:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2016 |
| Most Recent Quarter (mrq) | March 31, 2017 |
| Next Fiscal Year End | December 31, 2017 |
Profitability
| Profit Margin | 1.78% |
| Operating Margin (ttm) | 2.11% |
| Gross Margin | 13.05% |
| EBITDA Margin | 4.82% |
Management Effectiveness
| Return on Assets (ttm) | 1.05% |
| Return on Equity (ttm) | 1.93% |
Income Statement
| Revenue (ttm) | 107.87B KRW |
| Revenue Per Share (ttm) | 2659.12 KRW |
| Quarterly Revenue Growth (yoy) | -11.60% |
| Gross Profit (ttm) | 14.55B KRW |
| EBITDA | 5.2B KRW |
| Net Income Avi to Common (ttm) | 1.92B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | -83.39% |
Balance Sheet
| Total Cash (mrq) | 11.83B KRW |
| Total Cash Per Share (mrq) | 291.63 KRW |
| Total Debt (mrq) | 15.83B KRW |
| Total Debt/Equity (mrq) | 16.15 KRW |
| Current Ratio (mrq) | 3.675 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 11.2B KRW |
| Levered Free Cash Flow (ttm) | 9.91B KRW |
Profile of Hwail Pharmaceutical Co.,Ltd.
| Country | South Korea |
| State | N/A |
| City | Seongnam-si |
| Address | Korea BIO PARK C |
| ZIP | N/A |
| Phone | 82 2 512 2592 |
| Website | https://www.hwail.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Hwail Pharmaceutical Co.,Ltd. develops pharmaceutical raw materials in South Korea. It also provides finished formulation products; and food raw materials and functional health food ingredients. The company was founded in 1974 and is based in Seongnam-si, South Korea.
Q&A For Hwail Pharmaceutical Co.,Ltd. Stock
What is a current 061250.KQ stock price?
Hwail Pharmaceutical Co.,Ltd. 061250.KQ stock price today per share is 1571 KRW.
How to purchase Hwail Pharmaceutical Co.,Ltd. stock?
You can buy 061250.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hwail Pharmaceutical Co.,Ltd.?
The stock symbol or ticker of Hwail Pharmaceutical Co.,Ltd. is 061250.KQ.
How many shares does Hwail Pharmaceutical Co.,Ltd. have in circulation?
The max supply of Hwail Pharmaceutical Co.,Ltd. shares is 64.19M.
What is Hwail Pharmaceutical Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Hwail Pharmaceutical Co.,Ltd. PE Ratio is now.
What was Hwail Pharmaceutical Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Hwail Pharmaceutical Co.,Ltd. EPS is 0 KRW over the trailing 12 months.